Diagnosis and Prognosis for Aortic Aneurysm aNd Dissection in Anzhen(DPANDA) Study

Recruiting now

Conditions studied: Aortic Aneurysm, Aortic Dissection

In brief

The registry study aims to determine serial biomarkers to diagnosis and prognosis of aortic aneurysm/aortic dissection.

Key facts

Study ID

NCT03233087

Run by

Beijing Institute of Heart, Lung and Blood Vessel Diseases

People needed

1500

Starts

2014-03-01

Expected to finish

2028-12-31

Last updated by the study team

2024-06-27

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Retrospective
• All patients who were referred to the surgical service for evaluation and management of aortic dissection were included.
• Perspective
• Patients with initial suspicion of having AAD were perspectively enrolled.

You may not qualify if…

• Retrospective
• Patients who received packed red blood cells, whole blood, or platelets less than 10 days before the blood sample was taken;
• Patients with aortic trauma, pseudo aneurysm, history of heart failure, renal dysfunction, severe pulmonary diseases, or active cancer;
• Patients who entered the hospital for checkups after surgery.
• Perspective
• Patients in whom there is little or no suspicion of a life-threatening disease;
• Patients with confirmed acute myocardial infarction,angina or pulmonary embolism
• The symptoms were clearly not related to AD (e.g. pleurisy, pneumonia, acute abdominal diseases).

Where it is running

• Beijing Anzhen Hospital — Beijing, Beijing Municipality, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.